Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.00 (0.00%)
Bid:
27.00
Ask:
28.00
Spread: 1.00 (3.704%)
Market Cap: £10.94m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Typo correction to Final Results

5 Mar 2020 17:47

RNS Number : 2069F
Airea PLC
05 March 2020
 

The following amendment has been made to the 'Final results for the year ended 31st December 2019' announcement released on 5 March 2020 at 07:00 under RNS No 0570F.

In the consolidated Balance Sheet there was duplication of the heading 'Deferred tax' under Non-current liabilities. The second reference to 'Deferred tax' under Non-current liabilities in the previous announcement now reads 'Loans and borrowings'.

 All other details remain unchanged. The full amended consolidated balance sheet is shown below.

Airea plc

Final results for the year ended 31st December 2019

Consolidated Balance Sheet

Year ended 31 December 2019

2019

2019

2018

2018

£'000

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

4,229

5,108

Intangible assets

39

95

Investment property

3,600

3,400

Deferred tax asset

847

1,466

Right-of-use-asset

1,233

-

_______

_______

9,948

10,069

Current assets

Inventories

5,461

6,797

Trade and other receivables

2,112

2,330

Cash and cash equivalents

2,957

2,732

_______

_______

10,530

11,859

_______

_______

Total assets

20,478

21,928

_______

_______

Current liabilities

Trade and other payables

(2,412)

(3,571)

Provisions

(320)

(320)

Lease liabilities

(329)

(187)

Loans and borrowings

(562)

-

_______

_______

(3,623)

(4,078)

Non-current liabilities

Deferred tax

(457)

(305)

Pension deficit

(1,472)

(3,688)

Lease liabilities

(323)

(323)

Loans and borrowings

(724)

-

_______

_______

(2,976)

(4,316)

_______

_______

Total liabilities

(6,599)

(8,394)

_______

_______

Net assets

13,879

13,534

_______

_______

Equity

Called up share capital

10,339

10,339

Share premium account

504

504

Own shares

(1,839)

-

Share based payment reserve

85

-

Capital redemption reserve

3,617

3,617

Revaluation reserve

3,048

3,096

Retained earnings

(1,875)

(4,022)

_______

_______

Total equity

13,879

13,534

_______

_______

 

Enquiries:

Neil Rylance 01924 266561

Chief Executive Officer

 

Paul Stevenson 01924 266561

Group Finance Director

 

Peter Steel / Ben Farrow 020 7496 3061

N+1 Singer

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUVOBRRBUORAR
Date   Source Headline
16th Jun 20269:49 amRNSDirector / PDMR Dealing
8th Jun 20265:10 pmRNSExercise of Options / PDMR notification
6th May 20263:06 pmRNSResult of AGM
6th May 20262:00 pmRNSAGM Statement
20th Apr 202612:23 pmRNSDirector/PDMR Dealing
26th Mar 20267:00 amRNSFinal Results for the year ended 31 December 2025
9th Mar 20267:00 amRNSNotice of Results
11th Feb 20268:52 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSPre-close Trading Update
1st Oct 20259:08 amRNSHolding(s) in Company
30th Sep 20254:12 pmRNSDivestment of Investment Property
30th Sep 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSPre-close Trading Update and Notice of Results
7th May 20253:06 pmRNSResult of AGM
7th May 202512:01 pmRNSDirector/PDMR Dealing
7th May 202512:00 pmRNSAGM Statement
28th Mar 20257:00 amRNSDirector/PDMR Dealings
27th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20257:00 amRNS-ROpening of Dubai Showroom
23rd Jan 202510:40 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSPre-close Trading Update
26th Sep 202411:43 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSInterim Results
6th Aug 20247:00 amRNSPre-close Trading Update and Notice of Results
28th Jun 20247:00 amRNSLong Term Incentive Plan Awards
8th May 20243:07 pmRNSResult of AGM
8th May 202412:00 pmRNSAGM Statement
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.